The protein expression of hRNase5/ANG is enhanced during inflammation, pregnancy, and certain pathological conditions, such as cardiovascular disorders [38–41], as well as in several malignant diseases and cancer types, such as pancreatic, colorectal, prostate, ovarian, thyroid, and bladder cancers as well as acute myelogenous leukemia, and multiple myeloma [37, 42–44]. The gene discussed is ANG; the disease is cancer.